Stay updated on Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Site version updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T02:02:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck to the study's listed conditions.
    Difference
    0.1%
    Check dated 2026-04-01T12:31:22.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T07:12:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma to the Conditions section and included the Genetic and Rare Diseases Information Center as a Resources link.
    Difference
    0.2%
    Check dated 2026-03-18T02:15:52.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-10T15:28:42.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Sponsor-related navigation text and links referencing Bayer were removed from the study page.
    Difference
    0.2%
    Check dated 2026-02-24T09:21:33.000Z thumbnail image

Stay in the know with updates to Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.